Edition:
United Kingdom

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

47.97USD
14 Dec 2018
Change (% chg)

$-2.98 (-5.85%)
Prev Close
$50.95
Open
$50.24
Day's High
$50.65
Day's Low
$47.52
Volume
219,368
Avg. Vol
241,595
52-wk High
$82.68
52-wk Low
$33.06

Select another date:

Mon, Aug 27 2018

Esperion's combo therapy lowers cholesterol level by 35 percent, shares surge

Esperion Therapeutics Inc said on Monday a combination of its drug, bempedoic acid, taken along with Merck's Zetia lowered cholesterol level by 35 percent in a late-stage study, sending the company's shares up as much as 11 percent.

UPDATE 1- Esperion's combo therapy lowers cholesterol level by 35 pct, shares surge

Aug 27 Esperion Therapeutics Inc said on Monday a combination of its drug, bempedoic acid, taken along with Merck's Zetia lowered cholesterol level by 35 percent in a late-stage study, sending the company's shares up as much as 11 percent.

Select another date: